Literature DB >> 17686862

Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia.

Todd P Margolis1, Fred L Elfman, David Leib, Nazzy Pakpour, Kathleen Apakupakul, Yumi Imai, Cindy Voytek.   

Abstract

Careful studies of mouse trigeminal ganglia (TG) latently infected with herpes simplex virus type 1 (HSV-1) indicate the presence of productive cycle viral gene products and persistent immune response, suggesting ongoing spontaneous viral reactivation in these tissues. In the present study we set out to determine whether infectious virus is present in murine TG latently infected with HSV-1 (KOS). At 37 days after ocular inoculation we found a small amount of infectious virus in ca. 6% of latently infected murine TG. Furthermore, the amount of infectious virus that we detected (PFU per viral antigen-positive neuron) was similar to that detected in acutely infected ganglia. We conclude that spontaneous reactivation of infectious HSV-1 occurs in the mouse TG and is likely the principle cause of viral protein expression in these tissues. We next examined the role of latency-associated transcript (LAT) in spontaneous ganglionic reactivation by examining ganglia latently infected with KOS dlLAT1.8, a LAT deletion virus. Through the use of immunocytochemistry we found that KOS dlLAT1.8 had a rate of spontaneous ganglionic reactivation very similar to that of HSV-1 (KOS). Studying spontaneous ganglionic reactivation of HSV in the mouse TG allows a direct study of viral reactivation from latently infected neurons without the potential confounders and complicating downstream events that accompany the study of viral reactivation by explantation or peripheral viral shedding. Since most cases of human viral shedding and reactivation are not associated with a known trigger, spontaneous ganglionic reactivation of HSV-1 may be a better model of human disease than existing models.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686862      PMCID: PMC2045564          DOI: 10.1128/JVI.00243-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation.

Authors:  N M Sawtell
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Recurrence of herpes simplex virus in rabbit eyes: results of a three-year study.

Authors:  P R Laibson; S Kibrick
Journal:  Invest Ophthalmol       Date:  1969-06

4.  Quantitation and kinetics of induced HSV-1 ocular shedding.

Authors:  J M Hill; J B Dudley; Y Shimomura; H E Kaufman
Journal:  Curr Eye Res       Date:  1986-03       Impact factor: 2.424

5.  Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.

Authors:  S H Chen; D A Garber; P A Schaffer; D M Knipe; D M Coen
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

6.  Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Herpetic Eye Disease Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  2000-12

7.  Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.

Authors:  H Openshaw; L V Asher; C Wohlenberg; T Sekizawa; A L Notkins
Journal:  J Gen Virol       Date:  1979-07       Impact factor: 3.891

8.  Reactivation of murine latent HSV infection by epinephrine iontophoresis.

Authors:  D E Willey; M D Trousdale; A B Nesburn
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-08       Impact factor: 4.799

9.  Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse.

Authors:  A B Tullo; C Shimeld; W A Blyth; T J Hill; D L Easty
Journal:  J Gen Virol       Date:  1982-11       Impact factor: 3.891

10.  A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5' end of the latency-associated transcript produces a protein in infected rabbits.

Authors:  Guey-Chuen Perng; Barak Maguen; Ling Jin; Kevin R Mott; John Kurylo; Lbachir BenMohamed; Ada Yukht; Nelson Osorio; Anthony B Nesburn; Gail Henderson; Melissa Inman; Clinton Jones; Steven L Wechsler
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more
  46 in total

1.  Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice.

Authors:  Sariah J Allen; Kevin R Mott; Mandana Zandian; Homayon Ghiasi
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

2.  Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.

Authors:  Arif A Khan; Ruchi Srivastava; Aziz A Chentoufi; Roger Geertsema; Nhi Thi Uyen Thai; Gargi Dasgupta; Nelson Osorio; Mina Kalantari; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

Review 3.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

4.  Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.

Authors:  Lbachir BenMohamed; Nelson Osorio; Ruchi Srivastava; Arif A Khan; Jennifer L Simpson; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-05-22       Impact factor: 2.643

5.  Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.

Authors:  Konasale M Prasad; Shaun M Eack; Matcheri S Keshavan; Robert H Yolken; Satish Iyengar; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

6.  Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.

Authors:  Shaohui Wang; Alexander V Ljubimov; Ling Jin; Klaus Pfeffer; Mitchell Kronenberg; Homayon Ghiasi
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

7.  Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation.

Authors:  Anna R Cliffe; Jesse H Arbuckle; Jodi L Vogel; Matthew J Geden; Scott B Rothbart; Corey L Cusack; Brian D Strahl; Thomas M Kristie; Mohanish Deshmukh
Journal:  Cell Host Microbe       Date:  2015-12-09       Impact factor: 21.023

8.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

Review 9.  A cultured affair: HSV latency and reactivation in neurons.

Authors:  Angus C Wilson; Ian Mohr
Journal:  Trends Microbiol       Date:  2012-09-07       Impact factor: 17.079

10.  Efficient quiescent infection of normal human diploid fibroblasts with wild-type herpes simplex virus type 1.

Authors:  Robert McMahon; Derek Walsh
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.